DIA Diagnostyka S.A.

36.99USD148.80 PLN · GPW-2.11%Mkt Cap: 1.25B USDP/E: 19.71

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers…

Key Statistics

Company
Market Cap1.25B USD
Enterprise Value1.55B USD
Revenue (TTM)642.53M USD
Gross Profit473.70M USD
Net Income (TTM)62.55M USD
Revenue/Share19.03 USD
Last Price36.99 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.6K
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLDGNST00012
Valuation
P/E (Trailing)19.71
P/E (Forward)15.28
PEG—
EV/EBITDA10.30
EV/Revenue2.42
P/S1.94
P/B9.85
EPS (TTM)1.88 USD
EPS (Forward)—
52W Range
35.827% of range51.71
52W High51.71 USD
52W Low35.82 USD
Profitability
Gross Margin79.05%
Oper. Margin14.93%
EBITDA Margin23.46%
Profit Margin10.44%
ROE47.62%
ROA12.16%
ROIC19.70%
ROCE24.55%
Growth
Revenue Growth16.10%
Earnings Growth-10.10%
Cash Flow & Leverage
Operating CF137.17M USD
CapEx (TTM)50.91M USD
FCF Margin7.23%
FCF Yield3.72%
Net Debt299.31M USD
Net Debt/EBITDA1.99
Net Debt/FCF6.44
Balance Sheet
Debt/Equity2.05
Current Ratio0.81
Quick Ratio0.70
Book Value/Sh3.76 USD
Cash/Share0.13 USD
Dividends
Fwd Div Rate1.09 USD
Trail. Div Rate1.09 USD
Div. Yield2.89%
5Y Avg Yield—
Payout Ratio58.28%
Ex-Div DateJun 1, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)47.58 USD
Upside (mean)+28.6%
Target Range42.26 USD – 53.45 USD
42.26+28.6% to mean53.45
# Analysts7
Ownership
Shares Out.33.76M
Float16.40M
Insiders47.20%
Institutions16.83%
Technical
SMA 5039.01 (-5.2%)
SMA 20041.53 (-10.9%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)34.12K
Avg Vol (10d)27.73K
Technical Indicators
RSI (14)39.4
MACD-1.4680
MACD Signal-1.8396
MACD Hist.+0.3715
BB Upper39.13 USD
BB Middle37.65 USD
BB Lower36.17 USD
BB Width7.88%
ATR (14)0.8049 USD
Vol Ratio (20d)1.08x

About Diagnostyka (WSE: DIA)

›

Diagnostyka (WSE: DIA) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 8,645 employees.

The shares were at 148.80 PLN on 19 November 2026, down 17.9% over 52 weeks. Its 52-week range is 144.10 PLN to 208.00 PLN: the price is 28.5% below the high and 3.3% above the low.

At a market capitalisation of 5.02B PLN, it trades at 19.7 times trailing earnings and 15.3 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 45% for DIA. It pays a dividend yielding 2.89% (it pays out 58% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Diagnostyka reports return on equity of 47.6%, an operating margin of 14.9% and revenue up 16.1% year over year.

Its debt exceeds its cash by 1.20B PLN, a debt-to-equity ratio of 2.05. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 7 analysts cover the stock; their mean price target of 191.39 PLN is 28.6% above the current price. The next earnings report is expected on 26 November 2026.